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CC BY-NC-ND license (http://creativeAbstract The Hippo signaling pathway was first discovered in Drosophila as a conserved regu-
lator of organ size. Genetic inactivation in mice demonstrates that the Hippo pathway func-
tions as a fundamental inhibitor of organ growth during development, and as a critical
tumor suppressor in epithelial tissues.
Copyright ª 2014, Chongqing Medical University. Production and hosting by Elsevier B.V. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/3.0/).The Hippo signaling pathway was first discovered in
Drosophila as a conserved regulator of organ size. Genetic
inactivation in mice demonstrates that the Hippo pathway
functions as a fundamental inhibitor of organ growth during
development, and as a critical tumor suppressor in
epithelial tissues.1 The prototype pathway consists of a
serine/threonine kinase cascade regulated by the tumor
suppressor Hippo (Mst1 and Mst2 in mammals) and the
downstream oncoprotein Yki in Drosophila (YAP and TAZ in
mammals), which transcriptionally activates target genes
and regulates cell proliferation, cell survival, differentia-
tion, cell polarity, and mechanotransduction.1 Like other.edu (T.-C. He).
ity of Chongqing Medical
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ng Medical University. Production
commons.org/licenses/by-nc-nd/well-known signaling pathways, the Hippo pathway relays
signals from the plasma membrane into the nucleus. How-
ever, this pathway does not have dedicated extracellular
signaling molecules and/or receptors. Increasing evidence
shows that the core Hippo kinase cascade integrates mul-
tiple upstream signaling inputs, and that actin cytoskeleton
or cellular tension appears to be the master mediator,
integrating and transmitting upstream signals to the core
Hippo signaling cascade.
An earlier study showed that the Hippo pathway may
restrict Wnt/b-catenin signaling by promoting an interac-
tion between TAZ and Disheveled (DVL) in the cytoplasm,
inhibiting CK1d/ε-mediated phosphorylation of DVL.2 How-
ever, it has been recently reported that YAP forms a tran-
scriptional complex with b-catenin and TBX5, and that
the b-catenin-YAP-TBX5 complex drives cell survival and
oncogenesis.3 TAZ was also shown to serve as aand hosting by Elsevier B.V. This is an open access article under the
3.0/).
128 Z. Wang et al.downstream mediator of Wnt/b-catenin signaling in a
Hippo-independent fashion.4 Thus, the Hippo transducers
YAP/TAZ have been reported to play positive, as well as
negative, roles in Wnt signaling.
A recent study published in Cell may provide further
insight into the mechanisms through which YAP/TAZ may
orchestrate the Wnt response.5 In the presence of Wnt, it
has been shown that YAP/TAZ proteins are released from
the destruction complex, allowing for nuclear accumulation
and driving Wnt/YAP/TAZ-dependent biological effects.5
Without Wnt, YAP/TAZ are transcriptionally inactivated
by sequestration in the destruction complex through bind-
ing to Axin1, causing b-TrCP recruitment to the destruction
complex and subsequent b-catenin degradation. On the
other hand, when Wnt is present, YAP/TAZ proteins
are released from the destruction complex and b-
TrCP recruitment cannot occur; this is essential for Wnt/b-
catenin signaling.5 Mechanistically, YAP/TAZ and LRP6
compete for the same domain of Axin e to the extent that
the association of Axin to YAP/TAZ is incompatible with
Axin-LRP6 association. Thus, Axin/YAP/TAZ complexes
dominate in Wnt-OFF cells, whereas Axin/LRP6 complexes
dominate in Wnt-ON cells. Wnt signaling physically dis-
lodges YAP/TAZ from the destruction complex, causing
them to undergo nuclear accumulation and activate
expression of target genes. Accordingly, it was shown that
cytoplasmic, but not nuclear, YAP/TAZ are b-catenin in-
hibitors. Furthermore, YAP/TAZ are required for crypt
regeneration and Apc deficiency-induced intestinal crypt
overgrowth.5 Taken together, these biochemical, func-
tional, and genetic findings strongly suggest that YAP andTAZ may be integral components of the b-catenin
destruction complex, which serves as a cytoplasmic sink for
YAP/TAZ. Nonetheless, the precise role of Hippo in Wnt
signaling remains to be fully understood, as YAP1 or TAZ
knockout animals do not phenocopy the loss of Wnt
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